Annexin Pharmaceuticals AB (publ) (STO: ANNX)

ANNX Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 3, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	257	88	154	137	125	31
Market Cap Growth	156.30%	-42.68%	12.35%	9.62%	302.27%	3.53%
Enterprise Value	232	87	117	130	94	20
Last Close Price	0.48	0.24	0.57	0.57	1.00	0.66
PB Ratio	10.26	4.70	5.11	2.94	6.07	2.71
P/TBV Ratio	12.38	4.79	5.20	2.97	6.27	2.91
Debt / Equity Ratio	-	-	-	-	-	0.02
Quick Ratio	7.53	3.03	5.05	8.33	4.07	1.00
Current Ratio	7.66	3.13	5.16	8.37	5.07	3.01
Return on Equity (ROE)	-407.85%	-179.93%	-105.95%	-154.80%	-275.41%	-110.49%
Return on Assets (ROA)	-147.71%	-86.77%	-56.80%	-84.72%	-135.40%	-58.21%
Return on Capital (ROIC)	-184.36%	-112.42%	-66.10%	-98.02%	-172.40%	-69.42%
Earnings Yield	-29.78%	-49.84%	-26.41%	-37.99%	-35.34%	-91.12%
FCF Yield	-17.12%	-49.10%	-26.70%	-32.81%	-31.31%	-82.66%
Buyback Yield / Dilution	-130.52%	-14.23%	-78.30%	-33.40%	-247.79%	-42.77%
Total Shareholder Return	-130.52%	-14.23%	-78.30%	-33.40%	-247.79%	-42.77%

Source: S&P Capital IQ. Standard template. Financial Sources.